NCT05334121

Safety Analysis of Chronic Intake of a β-alanine Supplement

Randomized Clinical Trial to Analyze the Safety of Chronic Intake of a β-alanine Supplement in Active Individuals

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Universidad Católica San Antonio de Murcia · Academic / Other
• Sex: Male
• Age: 18 Years – 40 Years
• Healthy volunteers: Accepted

Summary

Single-center, double-blind, placebo-controlled clinical trial with two arms (product and placebo) to analyze the safety of beta-alanine consumption in active people.

Detailed description

After recruitment, subjects will be randomized and assigned to one of the two arms of the study: beta-alanine group or control group (placebo). Subjects must be active people, and will take a dose of 15 g per day of the product for 4 weeks.

Conditions

• Product Safety

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Beta-alanine	The product will be consumed every day for 4 weeks. Four intakes of 3g each, separated by three hours each, will be carried out.
OTHER	Control product consumption	Product with identical characteristics to the experimental product. The product will be consumed every day for 4 weeks. Four intakes of 3g each, separated by three hours each, will be carried out.

Timeline

• Start date: 2022-03-21
• Primary completion: 2022-04-25
• Completion: 2022-05-31
• First posted: 2022-04-19
• Last updated: 2022-07-26

Locations

1 site across 1 country: Spain